Private Health Insurance (Prostheses) Amendment Rules (No. 4) 2019 (Cth)

Case
No judgment structure available for this case.

Private Health Insurance (Prostheses) Amendment Rules (No. 4) 2019

I, Karen Binnekamp, delegate of the Minister for Health, make the following Rules.

Dated 14 June 2019

Karen Binnekamp

Acting Assistant Secretary

Office of Health Technology Assessment

Technology Assessment and Access Division

Department of Health

Contents

1Name

This instrument is the Private Health Insurance (Prostheses) Amendment Rules (No. 4) 2019.

2Commencement

This instrument commences the day after registration.

3Authority

This instrument is made under item 4 of the table in section 333-20 of the Private Health Insurance Act 2007.

4Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1Amendments

Private Health Insurance (Prostheses) Rules 2019 (No. 1)

  1. 1

    Rule 4 (definition of accredited podiatric surgeon)

    Repeal the definition (including the note).

2

Rule 4

Insert:

registered podiatric surgeon means a podiatric surgeon who holds specialist registration in the specialty of podiatric surgery under the National Law.

Note The registration requirements for a registered podiatric surgeon for the purpose of these Rules are the same registration requirements for podiatric surgeons as set out in rule 8 of the Private Health Insurance (Accreditation) Rulesas made from time to time.

3

Paragraph 7(a)

Omit “an accredited podiatric surgeon”, substitute “a registered podiatric surgeon”

4

Rule 13

Repeal the rule (not including the note), substitute:

13. Listing criteria for prostheses to be listed in Part C of Schedule 1

For a listing application to be granted to list a kind of prosthesis in Part C of Schedule 1, the listing criterion is that the kind of prosthesis is:

(i) an insulin infusion pump;

(ii) an implantable cardiac event recorder;

(iii) a cardiac home/remote monitoring system;

(iv) a cardiac ablation catheter;

(v) a mapping catheter for catheter cardiac ablation;

(vi) a patch for cardiac ablation;

(vii) a monopolar device for surgical cardiac ablation;

(viii) a bipolar device for surgical cardiac ablation;

(ix) a system for surgical cardiac ablation; or

(x) a probe for surgical cardiac ablation.

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0